Peter Ciszewski
Articles
Trial for Anti-Lung Cancer Compound ASA404 Progresses to Phase III
May 21st 2010A pivotal phase III study is currently underway to evaluate the efficacy and safety of Novartis' novel anti-cancer compound ASA404 in patients with non–small cell lung cancer (NSCLC). NSCLC is the most prevalent cause of cancer death among men and women in the United States and globally.
Read More
Latest Updated Articles
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Published: November 21st 2024 | Updated: November 24th 2024
Open-Label Study Finds Aficamten Could Help Most oHCM Patients Avoid Surgery
Published: October 9th 2014 | Updated: November 24th 2024
Widespread "Yellow Bumps"
Published: November 19th 2024 | Updated: November 24th 2024
Laura Hamant, MD: Standardized Algorithm Increases VTE Prophylaxis Among Children
Published: November 18th 2024 | Updated: November 24th 2024
The Medical Sisterhood: Role Models and Mentorship, with Susan Taylor, MD, and Linda Stein Gold, MD
